Navigating the Labyrinth of Delivering Therapeutics to the Ear (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

Navigating the Labyrinth of Delivering Therapeutics to the Ear (1 of 1)

Caption

Current methods of drug delivery to the cochlea, such as intratympanic and intracochlear delivery, are invasive and require needles or scalpels. Delivery of cell therapies or nanoparticles through blood vessels (vascular delivery) represents an alternative and non-invasive approach. This material relates to a paper that appeared in the Mar. 6, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by S. Nyberg at Sunnybrook Research Institute in Toronto, ON, Canada; and colleagues was titled, "Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier."

Credit

S. Nyberg <i>et al., Science Translational Medicine</i> (2019)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.